Washington Capital Management’s Globus Medical GMED Stock Holding History

Washington Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$656K	Sell	8,300 -300	-3%	-$25.5K	0.43%	70
2026 Q1	$741K	Sell	8,600 -1,400	-14%	-$126K	0.63%	40
2025 Q4	$873K	Buy	10,000 +1,900	+23%	+$144K	0.71%	32
2025 Q3	$464K	Buy	8,100 +2,400	+42%	+$138K	0.33%	86
2025 Q2	$336K	Buy	+5,700	New	+$368K	0.25%	102
2024 Q3	–	Sell	-10,400	Closed	-$712K	–	115
2024 Q2	$712K	Hold	10,400	–	–	0.6%	45
2024 Q1	$558K	Hold	10,400	–	–	0.45%	74
2023 Q4	$554K	Buy	+10,400	New	+$507K	0.47%	69
2022 Q4	–	Sell	-4,700	Closed	-$280K	–	107
2022 Q3	$280K	Buy	+4,700	New	+$283K	0.28%	97
2020 Q1	–	Sell	-10,350	Closed	-$609K	–	97
2019 Q4	$609K	Hold	10,350	–	–	0.52%	43
2019 Q3	$529K	Buy	10,350 +2,100	+25%	+$100K	0.52%	48
2019 Q2	$349K	Buy	8,250 +2,350	+40%	+$102K	0.4%	78
2019 Q1	$292K	Buy	+5,900	New	+$267K	0.33%	92

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Washington Capital Management's GMED Position: Q2 2026 in Review

Washington Capital Management reduced its Globus Medical (GMED) stake by 3.5% in Q2 2026, selling an estimated $25.5K and leaving 8,300 shares worth $656K. The position accounts for 0.43% of the portfolio, ranked #70.

Washington Capital Management first reported a position in GMED in Q1 2019 and has held it in 13 quarters since. The position peaked at $873K in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Washington Capital Management held 8,300 shares of Globus Medical worth $656K as of Q2 2026.
Washington Capital Management sold 300 Globus Medical shares in Q2 2026, an estimated $25.5K.
Globus Medical made up 0.43% of Washington Capital Management's portfolio in Q2 2026, its #70 holding.
Washington Capital Management first reported a position in Globus Medical in Q1 2019 and has held it in 13 quarters since.
Washington Capital Management's Globus Medical position peaked at $873K in Q4 2025.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Washington Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.